Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AD26.COV2.S for Immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 113 adverse event reports in the FDA FAERS database where AD26.COV2.S was used for Immunisation.

Most Reported Side Effects for AD26.COV2.S

Side Effect Reports % Deaths Hosp.
Covid-19 58 13.4% 0 18
Fatigue 47 10.9% 0 12
Off label use 43 9.9% 0 13
Headache 42 9.7% 0 6
Pain 41 9.5% 0 18
Pyrexia 40 9.2% 0 11
Malaise 38 8.8% 0 12
Arthralgia 32 7.4% 0 11
Chills 31 7.2% 0 8
Nausea 25 5.8% 0 9
Pain in extremity 24 5.5% 1 5
Covid-19 immunisation 22 5.1% 0 6
Diarrhoea 21 4.9% 0 8
Drug ineffective 20 4.6% 0 4
Feeling abnormal 20 4.6% 0 3

Other Indications for AD26.COV2.S

Covid-19 immunisation (190) Covid-19 prophylaxis (64) Product used for unknown indication (37)

Other Drugs Used for Immunisation

INFLUENZA VIRUS VACCINE (560) PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281) COVID-19 VACCINE NOS (269) TOZINAMERAN (207) MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148) PNEUMOCOCCAL VACCINE POLYVALENT (140) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (123) STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111) MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN (110)

Related Pages

AD26.COV2.S Full Profile All Immunisation Drugs AD26.COV2.S Demographics AD26.COV2.S Timeline